Skip to main content

Medical Services

Medical Services
Recovery Unplugged treatment facilities will be the sites for a trial evaluating an auricular device that could ease the painful symptoms associated with opiate withdrawal.
Medical Services
Prominent addiction medicine and research leader Mark Gold, MD has joined the board of directors at outpatient treatment organization Spero Health.
Medical Services
A communication this week from the Food and Drug Administration suggests continuing concern about the safety of products containing the cannabis-derived compound CBD.
Medical Services
An analysis of opioid use disorder treatment under Medicaid in North Carolina finds that while more patients are receiving evidence-based care, the service gap continues to widen.
Medical Services
A life sciences company that is testing a sustained-release risperidone product for psychosis is now pursuing an effort to improve adherence to naltrexone for opioid dependence.
General Psychiatry
A report released today by Quest Diagnostics and the Center on Addiction shows some inconsistencies between physician perspectives and patient behaviors regarding prescription drug use.
Medical Services
Initial research is helping to confirm Hazelden Betty Ford Foundation's move to established focused treatment for opioid addiction that includes extended medication treatment.
Addiction Professional
Fentanyl overdose deaths climbed 14% in 2018, per CDC data, and a report released this week by not-for-profits Drug Strategies and Shatterproof studies the states hit hardest and how they have responded.
Medical Services
The Hampden County, Mass., corrections system has moved fully into medication-assisted treatment for inmates with substance use disorders, a practice that can be instructive for other jail systems.
Medical Services
A national study from the Cleveland Clinic finds a substantial increase in hospitalizations for endocarditis that were related to substance use.
Medical Services
A Canadian company has acquired the drug development program for a derivative of ibogaine, a potential treatment for opioid addiction.
Back to Top